| Literature DB >> 30082652 |
Andrzej Bak1, Violetta Kozik2, Malgorzata Walczak3, Justyna Fraczyk4, Zbigniew Kaminski5, Beata Kolesinska6, Adam Smolinski7, Josef Jampilek8.
Abstract
The pharmacophore properties of a new series of potential purinoreceptor (P2X) inhibitors determined using a coupled neural network and the partial least squares method with iterative variable elimination (IVE-PLS) are presented in a ligand-based comparative study of the molecular surface by comparative molecular surface analysis (CoMSA). Moreover, we focused on the interpretation of noticeable variations in the potential selectiveness of interactions of individual inhibitor-receptors due to their physicochemical properties; therefore, the library of artificial dipeptide receptors (ADP) was designed and examined. The resulting library response to individual inhibitors was arranged in the array, preprocessed and transformed by the principal component analysis (PCA) and PLS procedures. A dominant absolute contribution to PC1 of the Glu attached to heptanoic gating acid and Phe bonded to the linker m-phenylenediamine/triazine scaffold was revealed by the PCA. The IVE-PLS procedure indicated the receptor systems with predominant Pro bonded to the linker and Glu, Gln, Cys and Val directly attached to the gating acid. The proposed comprehensive ligand-based and simplified structure-based methodology allows the in-depth study of the performance of peptide receptors against the tested set of compounds.Entities:
Keywords: CoMSA; IVE-PLS; PX2 inhibitors; artificial dipeptide library; stochastic model validation
Mesh:
Substances:
Year: 2018 PMID: 30082652 PMCID: PMC6222794 DOI: 10.3390/molecules23081964
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Structure and activity of host molecules [13,16,17]. IC50 values were determined experimentally on the MCF-7 cell line.
| Comp. | Compound Structure | IC50 [μM] | Comp. | Compound Structure | IC50 [μM] |
|---|---|---|---|---|---|
|
|
| 12.30 |
|
| 139.78 |
|
|
| 7.40 |
|
| 46.29 |
|
|
| 49.40 |
|
| 20.44 |
|
|
| 35.11 |
|
| 169.7 |
|
|
| 135.73 |
|
| 32.14 |
|
|
| 51.39 |
|
| 43.95 |
|
|
| 85.37 |
|
| 111.81 |
|
|
| 30.02 |
|
| 30.92 |
|
|
| 29.08 |
|
| 80.83 |
|
|
| 117.61 |
|
| 33.85 |
Figure 1Projection of molecules described by Dragon (a) and by Sybyl (b) parameters on plane defined by PC1 and PC2.
Figure 2Projection of molecules described by Sybyl parameters on plane defined by PC1 and PC2 with their color-coded lipophilicity profile.
Figure 3Molecular plots show spatial sectors of the greatest contribution to inhibitory potency retrieved from the best CoMSA model. Colours code the sign of influence (a). Four possible combinations of mean charge and correlation coefficient are colour-coded for charge descriptors (b). Compound 2 was plotted as a reference molecule.
Figure 4Calculated lipophilicity profile (a) and ligand response values (b) obtained for set of 120 receptors (columns) and 20 compounds (rows).
Figure 5Histogram of response values for set of receptors with heptanoic (a) and decanoic (b) gating acids.
Figure 6Projection of receptors on plane defined by first and second principal components with type of lipid residue (heptanoic and decanoic).
Figure 7Projection of receptors on plane defined by first and second principal components with type of first (a) and second (b) residue used to build receptor structure.
Figure 8Projection of compound set on plane specified by first and second components with their activity profile (a), calculated lipophilicity values (b) and chemotype structure indicated (c).
Scheme 1Synthetic procedure used for preparation of ADR using SPOT methodology.
Figure 9In vitro IC50 activity for set of anticancer analogues.